Duncan Thomas: “It’s why I’m sitting here today.”

Meet Duncan Thomas, who was handed a virtual death sentence with his Stage IV terminal melanoma diagnosis.



Duncan was given 7-12 months to live after learning that the cancer had metastasized with tumors in his lungs and liver. He reached out to a friend from veterinary school who became the head of Translational Research at Bristol Myers, which opened the door to Duncan being one of the first patients to pilot a unique drug combination to try and battle the cancer.


In the middle of the clinical trial with Dr. Greg Daniels of Moores Cancer Center, the FDA fast tracked approval, and Duncan’s success had a part in bringing that treatment to more people who could survive and thrive after a terminal diagnosis. “It’s work that Greg and all of his people do, which is why I’m sitting here today.”


Watch¬†Duncan’s¬†story and how the¬†money raised through Padres Pedal the Cause is having¬†a real impact in accelerating cures.

    Scroll Up